All News about Lexaria Bioscience Corp WT
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Lexaria Grants License to AnodGen Bioceuticals
June 08, 2022
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
Exposures
Product Safety
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Lexaria Announces 2022 Annual Meeting Results
June 01, 2022
Via AccessWire
![](https://cdn.benzinga.com/files/images/story/2022/04/22/patent.jpeg?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/04/20/screenshot_2022-04-20_at_10.26.08_pm.png?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
![](https://cdn.benzinga.com/files/images/story/2022/04/13/screenshot_2022-04-14_at_12.24.37_am.png?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Lexaria Provides Update on Human Nicotine Study NIC-H22-1
April 12, 2022
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
![](https://cdn.benzinga.com/files/images/story/2012/screenshot_2022-03-16_at_10.24.01_pm.png?width=1200&height=800&fit=crop)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Lexaria Begins DehydraTECH-CBD Epilepsy Research Program
March 15, 2022
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Lexaria Granted Important New Oral Nicotine Patent
March 08, 2022
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/1529.jpg?v=0)
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.